Sanofi (NASDAQ:SNY) saw an upside of 0.32% to $51.81 after adding $0.16 on Monday. The 5-day average trading volume is 1,251,916 shares of the company’s common stock. It has gained $53.62 in the past week and touched a new high 1 time within the past 5 days. An average of 1,256,764 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,196,630.
SNY’s 1-month performance is 1.00% or $0.52 on its low of $49.97 reached on 08/03/23. The company’s shares have touched a 52-week low of $36.91 and high of $57.82, with the stock’s rally to the 52-week high happening on 04/26/23. YTD, SNY has achieved 6.99% or $3.39 and has reached a new high 18 times. However, the current price is down -10.39% from the 52-week high price.
Valuation Metrics
SNY stock has a beta of 0.57. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 2.54 while the price-to-book (PB) in the most recent quarter is 1.63.
Sanofi’s quick ratio for the period ended June 29 was 0.80, with the current ratio over the same period at 1.20. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.23, while the total debt to equity was 0.29. In terms of profitability, the gross margin trailing 12 months is 69.80%. The trailing 12-month EBITDA margin is 31.93%. The firm’s gross profit as reported stood at $33.39 billion against revenue of $47.82 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Sanofi’s cash and short-term investments amounted to $418.88 million against total debt of $21.03 billion. Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -47.1% to $9.38 billion, while revenue of $0.0 was 100.0% off the previous quarter. Analysts expected SNY to announce $1.55 per share in earnings in its latest quarter, but it posted $0.95, representing a -38.70% surprise. EBITDA for the quarter stood at more than $2.04 billion. SNY stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 57.14 billion, with total debt at $21.03 billion.
Let’s look briefly at Sanofi (SNY) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 04 August was 41.52% to suggest the stock is trending Neutral, with historical volatility in this time period at 22.19%.
The stock’s 5-day moving average is $51.79, reflecting a -2.90% or -$1.55 change from its current price. SNY is currently trading -0.02% above its 20-day SMA, +8.27% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -3.98% and SMA200 by+29.39%.
Stochastic %K and %D was 30.07% and 22.78% and the average true range (ATR) pointed at 0.94. The RSI (14) points at 43.77%, while the 14-day stochastic is at 37.00% with the period’s ATR at 0.89. The stock’s 9-day MACD Oscillator is pointing at -0.96 and -1.60 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Sanofi (NASDAQ: SNY), HSBC Securities launched coverage with a Buy rating.
